Royal Bank of Canada’s iBio IBIO Stock Holding History

Royal Bank of Canada’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7K	Buy	+3,891	New	+$9.03K	﹤0.01%	6315
2025 Q2	–	Sell	-1,000	Closed	-$4K	–	7163
2025 Q1	$4K	Buy	1,000 +992	+12,400%	+$3.86K	﹤0.01%	6406
2024 Q4	$0	Hold	8	–	–	﹤0.01%	7047
2024 Q3	$0	Sell	8 -29	-78%	-$57	﹤0.01%	7100
2024 Q2	$0	Sell	37 -15	-29%	-$32	﹤0.01%	7263
2024 Q1	$0	Sell	52 -26	-33%	-$33	﹤0.01%	7254
2023 Q4	$0	Buy	78 +70	+875%	+$306	﹤0.01%	7321
2023 Q3	$0	Sell	8 -23	-74%	-$199	﹤0.01%	7295
2023 Q2	$0	Sell	31 -90	-74%	-$1.7K	﹤0.01%	7422
2023 Q1	$5K	Buy	121 +108	+831%	+$2.78K	﹤0.01%	6568
2022 Q4	$0	Buy	13 +5	+63%	+$169	﹤0.01%	7436
2022 Q3	$1K	Hold	8	–	–	﹤0.01%	7199
2022 Q2	$1K	Sell	8 -27	-77%	-$4.06K	﹤0.01%	7132
2022 Q1	$8K	Sell	35 -61	-64%	-$12.8K	﹤0.01%	7052
2021 Q4	$26K	Buy	96 +32	+50%	+$12.2K	﹤0.01%	6679
2021 Q3	$34K	Buy	64 +11	+21%	+$6.85K	﹤0.01%	6381
2021 Q2	$40K	Buy	53 +9	+20%	+$6.56K	﹤0.01%	6183
2021 Q1	$33K	Buy	44 +1	+2%	+$871	﹤0.01%	6140
2020 Q4	$22K	Buy	43 +33	+330%	+$26.9K	﹤0.01%	6018
2020 Q3	$10K	Sell	10 -2	-17%	-$2.9K	﹤0.01%	5924
2020 Q2	$13K	Hold	12	–	–	﹤0.01%	5740
2020 Q1	$6K	Buy	12 +8	+200%	+$3.08K	﹤0.01%	5981
2019 Q4	$1K	Hold	4	–	–	﹤0.01%	6655
2019 Q3	$1K	Hold	4	–	–	﹤0.01%	6449
2019 Q2	$1K	Hold	4	–	–	﹤0.01%	6704
2019 Q1	$2K	Hold	4	–	–	﹤0.01%	6519
2018 Q4	$2K	Hold	4	–	–	﹤0.01%	6446
2018 Q3	$2K	Hold	4	–	–	﹤0.01%	6513
2018 Q2	$2K	Hold	4	–	–	﹤0.01%	6253
2018 Q1	$4K	Hold	4	–	–	﹤0.01%	5992
2017 Q4	$4K	Hold	4	–	–	﹤0.01%	6127
2017 Q3	$6K	Buy	4 +2	+100%	+$3.22K	﹤0.01%	6390
2017 Q2	$4K	Hold	2	–	–	﹤0.01%	6110
2017 Q1	$4K	Hold	2	–	–	﹤0.01%	6276
2016 Q4	$4K	Buy	+2	New	+$4.65K	﹤0.01%	6352
2016 Q3	–	Hold	0	–	–	–	6479
2016 Q2	–	Hold	0	–	–	–	6438
2016 Q1	–	Hold	0	–	–	–	6491
2015 Q4	–	Hold	0	–	–	–	6725
2015 Q3	–	Hold	0	–	–	–	6705
2015 Q2	–	Hold	0	–	–	–	6644
2015 Q1	–	Hold	0	–	–	–	6259
2014 Q4	–	Hold	0	–	–	–	6222
2014 Q3	–	Hold	0	–	–	–	6046
2014 Q2	–	Hold	0	–	–	–	6024
2014 Q1	–	Hold	0	–	–	–	5996
2013 Q4	–	Hold	0	–	–	–	6015
2013 Q3	–	Hold	0	–	–	–	6167
2013 Q2	–	Hold	0	–	–	–	5830

Other funds holding IBIO

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Royal Bank of Canada's IBIO Position: Q1 2026 in Review

Royal Bank of Canada opened a new position in iBio (IBIO) in Q1 2026: 3,891 shares worth $7K. The stake represents ﹤0.01% of the portfolio and ranks #6315 among its holdings. This is a return to the name: Royal Bank of Canada previously reported a position in IBIO as recently as Q1 2025.

Royal Bank of Canada first reported a position in IBIO in Q4 2016 and has held it in 35 quarters since. The position peaked at $40K in Q2 2021. 52 funds tracked by Wall St. Rank hold IBIO as of Q1 2026.

Royal Bank of Canada held 3,891 shares of iBio worth $7K as of Q1 2026.
iBio was a new Royal Bank of Canada position in Q1 2026.
iBio made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6315 holding.
Royal Bank of Canada first reported a position in iBio in Q4 2016 and has held it in 35 quarters since.
Royal Bank of Canada's iBio position peaked at $40K in Q2 2021.
52 funds tracked by Wall St. Rank held iBio as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.